Antiretroviral Therapy Adherence and Secondary Prevention of Human Immunodeficiency Virus

NACompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

April 30, 2019

Study Completion Date

April 30, 2019

Conditions
HIV
Interventions
BEHAVIORAL

cell phone reminders

Patients receive reminders, scheduled to occur daily at time(s) of scheduled antiretroviral therapy dosing.

BEHAVIORAL

contingency management for adherence

Patients will receive reinforcement in the form of vouchers for each video that they send in indicating adherence at the appropriate time.

Trial Locations (2)

06030-3944

University of Connecticut Health Center, Farmington

06520

Nathan Smith Clinic, Yale-New Haven Hospital, New Haven

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

UConn Health

OTHER

NCT01760759 - Antiretroviral Therapy Adherence and Secondary Prevention of Human Immunodeficiency Virus | Biotech Hunter | Biotech Hunter